Integrative snRNA‐seq, molecular docking and dynamics simulations identifies Lasmiditan as drug candidate for Alzheimer's disease is a research paper published in Clinical and Translational Medicine (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: U19AG055373
National Institutes of Health
Grant: P20GM109036
NIA NIH HHS
Grant: R01 AG068232
National Institutes of Health
Grant: 5P20GM109036-05
Tulane COBRE for Clinical and Translational Research in Cardiometabolic Diseases
National Institutes of Health
Grant: 5U19AG055373-04
Trans-omics integration of multi-omics studies for male osteoporosis
FWCI
1.99
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals